This is a routine, previously disclosed warrant exercise with no new capital raised. Monitor for any future share issuances under the GEM share purchase agreement, but this specific event is not a trading catalyst.
Price Chart
Executive Summary
Turn Therapeutics disclosed that GEM Yield Bahamas Limited exercised a warrant to purchase 1,192,207 shares on a cashless basis, resulting in the issuance of 579,664 new shares. This represents dilution of approximately 4% of fully diluted shares from the original warrant, though the actual dilution from the cashless exercise is lower. The transaction is a routine, previously disclosed warrant exercise with no new capital raised for the company, making it a neutral event with limited immediate market impact.
Key Facts
- GEM Yield Bahamas Limited exercised a warrant to purchase 1,192,207 shares on a cashless basis on August 13, 2026.
- The company issued 579,664 shares of common stock to GEM as a result of the cashless exercise.
- The original warrant was issued on October 8, 2025, with an exercise price of $5.03 per share.
- The warrant represented 4% of the company's fully diluted outstanding shares as of the original issuance date.
- No new capital was raised for the company from this exercise.
Financial Impact
Issuance of 579,664 shares via cashless warrant exercise; no new capital raised. Dilution is less than the original 4% fully diluted figure due to the cashless net-share settlement.
Risk Factors
- Potential future dilution from remaining GEM arrangements if any exist beyond this fully exercised warrant.
- No new capital raised; company's cash position unchanged.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-091002 |
| Document: 0001213900-26-091002-index-headers.html | 0001213900-26-091002 |
| Document: 0001213900-26-091002-index.html | 0001213900-26-091002 |
| Document: 0001213900-26-091002.txt | 0001213900-26-091002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEF 14A | $10.47 | awaiting T+60 | — | $10.48 (+0.10%) |
Oct 6, 2026 20d ago | 8-K | $12.10 | awaiting T+60 | — | $10.48 (−13.39%) |
Sep 10, 2026 6w ago | 8-K | $13.38 | awaiting T+60 | — | $10.48 (−21.67%) |
Sep 9, 2026 6w ago | 8-K | $13.75 | awaiting T+60 | — | $10.48 (−23.78%) |
Aug 18, 2026 10w ago | 8-K | $9.99 | awaiting T+60 | — | $10.48 (+4.90%) |
Jul 7, 2026 16w ago | 8-K | $9.71 $14.39 | ▲ +48.20% | ▲ +46.20% | $10.48 (+7.93%) |
Jun 3, 2026 20w ago | 8-K | $6.02 $10.11 | ▲ +67.94% | ▲ +65.44% | $10.48 (+74.09%) |
Jun 1, 2026 21w ago | 8-K | $6.33 $9.73 | ▲ +53.71% | ▲ +52.48% | $10.48 (+65.56%) |
May 27, 2026 21w ago | 8-K | $5.29 $9.54 | ▲ +80.34% | ▲ +78.46% | $10.48 (+98.11%) |
May 19, 2026 23w ago | 8-K | $4.55 $9.86 | ▲ +116.70% | ▲ +110.41% | $10.48 (+130.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers